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Abstract: This study investigates whether 6 weeks of intermittent normobaric hypoxic 
training (INHT) elicits improvements in maximal oxygen uptake (VO2max) or 
various measures of pulmonary function.  Training under hypoxic conditions has 
been suggested as a way to improve endurance performance at sea level and 
altitude.  This is possibly beneficial for the military, as situations occur where 
personnel are quickly deployed into areas of high altitude without sufficient time 
for acclimatization.  Therefore, 10 highly trained male members of the Army or 
Air Force Reserve Officers’ Training Corps (ROTC) performed maximal 
treadmill tests in normoxia (FiO2 - 20.9%, 744.0mmHg, PO2 - 155.5mmHg) and 
hypobaric hypoxia (HH) (FiO2 - 20.9%, 536.7mmHg, PO2 - 112.2mmHg).  Forced 
vital capacity (FVC), forced expiratory volume in 1 second, (FEV1), and peak 
expiratory flow rate (PEF) were also measured prior to treadmill testing with a 
portable spirometer.  After pre-testing subjects were split into experimental 
(EXP), INHT (n=6) or control (CON), normoxic training (NT) (n=4) groups and 
started training 3 days per week, 1 hour sessions.  The INHT group trained using 
normobaric hypoxia (FiO2 - 14.7%, 744.0mmHg, PO2 - 109.4mmHg).  Intensity 
of training was progressively increased to prevent under or overtraining and was 
based on maximal heart rate (MHR) achieved during their respective VO2max 
test.  Post-testing revealed a lack of significant changes in VO2max, FVC, FEV1, 
or PEF between or within groups due to INHT or NT.  Although, when percent 
increase was calculated the EXP group significantly improved in HH VO2max 
compared to the CON group (p < 0.05).  Also, combined VO2max scores were 
able to show significant improvements at HH and normoxia.  Furthermore, 
combined spirometric measures for FVC significantly decreased at HH, while 
PEF increased.  These results are favorable for military implementation to 
increase endurance in personal who are quickly deployed into altitude.  In 
addition, the training program implemented did prove to be effective for using 
INHT within current physical training.  Lastly, despite a change in pulmonary 
measures due to training, FVC and PEF were sensitive to changes in altitude and 
may be beneficial in detecting the onset of acute mountain sickness (AMS) or 
high altitude pulmonary edema (HAPE). 
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CHAPTER I 
 
 
INTRODUCTION 
 
The respiratory system encompasses three separate but related functions, including 
pulmonary ventilation, gas exchange, and internal respiration (24).  Pulmonary function consists 
of the mechanics for inspiration and expiration.  Gas exchange focuses on the transport and 
exchange of oxygen (O2) and carbon dioxide (CO2) throughout the body.  Lastly, internal 
respiration concentrates on the utilization of oxygen by tissues and ultimately the mitochondrial 
processes at a cellular level.  The current study concentrated primarily on the first mentioned, 
pulmonary function. 
 Altitude elicits many physiological responses such as, an increase in heart rate, increased 
release of erythropoietin (EPO) to stimulate greater production of red blood cells (RBC), and an 
increase in ventilation due to a decrease in the partial pressure of oxygen (PO2) (14).  These 
changes occur due to a decrease in atmospheric pressure.  As altitude increases, the atmospheric 
pressure decreases, causing the PO2 to decrease as well.  For example barometric pressure at sea 
level is 760 mmHg, PO2 in the air is 159 mmHg, and arterial PO2 is 100 mmHg.  These measures 
differ greatly when compared to an altitude of 3,048m (10,000 ft), where the barometric pressure 
is 523 mmHg, PO2 in the air is 109 mmHg, and arterial PO2 is 69 mmHg.  However, the actual 
percent of O2 always remains constant at 20.9%.   
 Since the air decreases in pressure the air also becomes molecularly less dense.  This has  
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major effects on all three aspects of the respiratory system (23, 29, 60).  Parameters the current 
study focused on were forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), 
and peak expiratory flow rate (PEF).  FVC is the total amount of air that can be forced from the 
lungs via maximal exhalation.  The amount of air forced out in the first second is known as the 
FEV1 and the PEF is an individual’s maximal rate of expiration.  These measures are useful in 
diagnosing lung diseases, detecting obstructions, as well as checking to see if a medication or 
pulmonary rehabilitation is having a positive effect. 
Training at altitude has traditionally included traveling to a high altitude region and 
staying for a period of 2-3 weeks.  Due to the high cost and time commitment, this method was 
typically only utilized by elite athletes.  To create similar conditions while still being close to 
home hypoxic conditions can be simulated, either by hypobaric chambers or normobaric 
generators.  Hypobaric hypoxia (HH) chambers work by pumping air out of an airtight chamber 
until the chamber reaches a pressure similar to a desired altitude, while the fraction of inspired 
oxygen (FiO2) remains constant at 20.9%.  Normobaric hypoxia generators (NH) simply dilute 
the ambient air with nitrogen so users are breathing in air with a lower FiO2, while the pressure is 
unaffected.  Due to these key differences HH chambers are considered to be a closer simulation to 
actual altitude when compared to NH.  However, HH chambers are expensive, require a large 
building for storage, and a trained technician to run the chamber. Additionally, while the HH 
chamber is in use it is typical to have medical personnel on hand. Whereas, NH generators are 
lightweight, easy to run, and can be used at any location for sleeping and living in, or for use 
while training.  The extent of the body’s physiological adaptations to these stressors is still highly 
debated due to the different ways HH and NH simulate hypoxic conditions (50). 
The primary concept behind training at altitude is to further increase the body’s oxygen-
carrying capacity (45).  The process begins in the kidneys, where production of EPO rises 
significantly, generating an increase of RBC production (hematopoiesis) in the red  marrow of 
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flat bones (19).  The increase in RBC improves the amount of O2 that can be carried throughout 
the body, thus increasing maximal aerobic capacity.  This is all a result of the decreased PO2 
which reduces the amount of oxygen available to the body.  However, hematopoiesis is not the 
only change that occurs due to hypoxic stress. Since air at altitude is less dense and there are less 
molecules of O2 for utilization the respiratory system mechanics must adapt as well.  When at 
altitude or HH the decrease in air density has been shown to decrease airway resistance, as a 
result maximal inspiration and expiration flow rates may be greater than at sea level (23). 
Conversely, mechanics of the lungs are under additional stress striving to increase the intake of 
O2.  Since the accessory respiratory muscles are working at a greater rate with lower efficiency, 
pulmonary endurance may be decreased (29). 
Due to the many changes that occur at altitude a period of acclimatization is typically 
utilized before performing high efforts of physical work.  Historically, experienced mountain 
climbers after passing 3,048m typically only climb 305m per day and rest for a day every 915m.  
Slowly ascending into extreme altitudes is important for proper acclimatization and minimizing 
adverse events.  However, present day military personal may be rapidly deployed into high 
altitude situations without adequate time to acclimate (53).  The initial decline in physical 
performance may compromise the ability for military personal to complete an operation 
successfully and at full physical potential.  Additionally, it may put personnel at an increased risk 
of suffering from acute mountain sickness (AMS) to the even more dangerous high altitude 
pulmonary edema (HAPE) or high altitude cerebral edema (HACE) (3).  NH generators may be a 
possible method to acclimatize soldiers before they are deployed into mountainous regions.  
Intermittent NH training (INHT), involves performing physical work under hypoxic stress to 
stimulate exercising at altitude.  The NH generators ease of use and portability make this one 
possible way the military could implement INHT to acclimatize soldiers while still living at their 
low-altitude base. 
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Considering the amount of physiological changes that occur at altitude, the differing 
methods for simulating altitude, and the importance of performing at altitude the purpose of this 
study was to examine the effects of a 6 week aerobic INHT intervention on pulmonary function 
and aerobic fitness at sea level and HH using current members of the Army and Air Force 
Reserve Officers' Training Corps (ROTC). 
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CHAPTER II 
 
 
LITERATURE REVIEW 
 
Altitude Training Benefits 
 Beneficial effects of training at altitude are highly debated amongst scientists, coaches, 
and athletes (15, 36) .  Furthermore, the time spent at altitude, how to train at altitude, the level of 
altitude, and when to come down from altitude add even more controversy to the topic (8, 44).  
Regardless, altitude training is still frequently used with elite endurance athletes of all types to 
supplement sea level training and to optimize both altitude and sea level performance (1, 4, 76). 
The interest in training at altitude greatly increased after the world watched athletes from areas of 
high altitude dominate endurance events at the 1968 Olympic Games held in Mexico City at an 
altitude of 2,300 m (7,544 ft) (2, 8, 36).  The basic theory of altitude training is to improve the 
body’s ability to transport and utilize oxygen, thus increasing their maximal oxygen uptake 
(VO2max) (36, 68).  
Levine and Stray-Gunderson (45) report the most commonly accepted theory as to why 
high altitude increases VO2max.  Suggesting that exposure to hypoxic conditions stimulates an 
increase in the production and the release of erythropoietin (EPO) from the kidney.  This in turn 
increases the production of erythrocytes in red bone marrow.  Overall, this escalates red blood 
cell (RBC) volume, which increases the body’s ability to transport oxygen to the working 
muscles.  Gore and Hopkins (33) later scrutinize this theory by constructing a review of the 
6 
 
current literature considering any alterative causes, but derived the same conclusions as Levine 
and Stray-Gunderson.  If an athlete is exposed to the correct amount of altitude exposure, which 
varies individually, erythropoietic changes will occur, increasing the body’s RBC volume, 
thereby increasing their VO2max.  However, these are not the only changes the human body 
undergoes after being exposed to hypoxic conditions (32).  Physiological adaptations to the 
pulmonary system, cardiovascular system, exercise economy, muscle buffering capacity, and 
even changes at a genetic level have all been documented (25, 51, 63, 70, 78).  Svedenhag (70) 
was able to report an increase in left ventricle muscle mass after 1 month of training and living at 
an altitude of 1,900 m in elite Swedish cross-country skiers.  Saunders et al. (63) found a decrease 
in the total VO2 over the last 60 seconds of a four-minute submaximal trial, demonstrating a 
decrease in the submaximal use of oxygen, thus an increase in running economy.  This decrease 
was after elite runners underwent a 20-day program of simulated live high (2,550 m) and train 
low (600 m).  Mizuno (51) et al. utilized muscle biopsies of the gastrocnemius in well-trained 
cross-country skiers to suggest an increase in muscle buffering capacity due to two weeks of 
training (2,700 m) and living (2,100 m) at altitude.  Zhu and Bunn (78) focused on a transcription 
factor known as hypoxia inducible factor-1 (HIF-1).  This factor is present in every cell in the 
body and is signaled when the body detects hypoxic conditions.  HIF-1 levels increase due to 
hypoxia and are responsible for simulating the body’s responses to the decrease in oxygen.  These 
studies demonstrate the extensiveness of changes occurring due to hypoxic exposure.  
Nevertheless, adaptations occurring in the pulmonary system due to training at altitude 
were the primary focus of the current study.  One of the initial changes that occurs due to 
exposure to altitude, is an increase in ventilation due to a decrease in the arterial partial pressure 
of oxygen (PO2).  After a study subjecting mice to hypoxia, Zhang et al. (77) determined proper 
lung function to be the most crucial factor for surviving severe hypoxia.  Hence, demonstrating 
why high altitude pulmonary edema (HAPE) is one the primary causes of death at altitude.  
Dempsey and Johnson (12) go on to challenge the general view that the lungs are overbuilt for 
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respiratory demands brought about by short-term high-intensity or endurance exercise, stating 
that the respiratory demands of highly trained endurance athletes may push the pulmonary system 
to near failure.  Dempsey et al. (13) later investigated respiratory adaptations to hypoxia and 
found there to be detriments in exercise capacity of approximately 5 to 10 % per every 304.8 m.  
The authors concluded that this occurs because highly trained endurance athletes already push 
their respiratory system towards failure, so when at altitude performance declines in order to 
protect the body.  These articles clarify the importance of the pulmonary system for performance 
and survival when experiencing hypoxia. 
Pulmonary Adaptations Due To Exercise Training 
“Athlete’s heart”, cardiac adaptations due to consistent rigorous exercise training, is well 
established and highly accepted among scientists in the field (57, 59).  The adaptations of the 
lungs however, specifically mechanical pulmonary function, are less agreed upon.  The current 
study focused on three main pulmonary function measures; forced vital capacity (FVC), forced 
expiratory volume in 1 second (FEV1), and peak expiratory flow rate (PEF).  Nourry et al. (54) 
and Fatima et al. (20) conducted studies that focused on short-term exercise training plans and the 
acute effects of exercise on pulmonary function.  Nourry et al. (54) investigated the effects of an 
8-week high-intensity training plan in 24 children.  They were able to report significant increases 
in FVC, FEV1, and PEF in the training group, compared to the control group who showed no 
change.  Fatima et al. (20) focused on 292 college-aged students performing 30 minutes of 
aerobic cycle ergometry at a moderate intensity for eight weeks, five days a week.  After the eight 
weeks subjects exhibited a significant increase in FEV1, but oddly a significant decrease in FVC.   
The authors were surprised as well with the decrease in FVC, but attributed it to the participants’ 
lack consistent effort while performing spirometry.  Measures taken via spirometer are always 
dependent on the instructions given and patient’s effort.  Further, Hulke et al. (29) and Thaman et 
al. (71) focused on similar training methods but extended the training periods over longer periods 
of time, all using college age populations.  Hulke et al. (29) implemented different intensity 
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levels, splitting their college age subject pool into three groups, high intensity (75% max heart 
rate (HR), low intensity (60% max HR), and sedentary control, while extending their protocol to 
20 weeks.  This resulted in a significant increase in FVC and PEF for the high intensity group, 
while the low intensity group saw fewer changes with only a significant increase in PEF, leading 
the investigators to conclude that high intensity training is more efficient at developing the 
cardiopulmonary system.  Thaman et al. (71) conducted a study using 100 of India’s Border 
Security Force (BSF) trainees and sedentary students both groups aged 18 to 23.  The BSF 
trainees underwent 9 months of demanding physical training consisting of moderate to severe 
workouts 7 days a week.  Due to the rigorous training FVC, FEV1, and PEF all increased 
significantly both within group and compared to the sedentary control group.  The authors 
concluded that structured physical training greatly improved lung function parameters in the BSF 
trainees. 
The articles above demonstrated the ability for exercise training to improve pulmonary 
function acutely.  In a similar manner, studies below attempted to provide evidence of the 
positive benefits of participating in athletics long-term.  Ghosh et al. (31) attempted to determine 
the differences in pulmonary capacities between different types of sports and compared to a 
sedentary group.  Their findings showed significant differences in FEV1 for soccer, field hockey, 
swimming, and volleyball compared to the sedentary group.  While basketball, boxing, cricket, 
soccer, and field hockey all showed significant differences in FVC compared to the sedentary 
group.  They concluded the athletes’ physical training may improve their lungs accessory muscles 
for inspiration and expiration.  Vedala et al. (72) conducted a similar study, but only focused on 
well-trained distance runners.  They found similar results; runners had significantly higher 
numbers for FVC, FEV1, and PEF compared to a sedentary control group.  The authors of this 
study built on the previous conclusions, stating physical activity will lead to improved pulmonary 
function, thus decreasing the risk for future pulmonary diseases.  Lastly, the study by Doherty and 
Dimitriou (16) had the largest sample size (n = 459) and focused on pulmonary function 
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differences between swimmers, land based athletes, and the sedentary.  They concluded that male 
swimmers significantly differed in FVC, FEV1, and PEF when compared to the sedentary group 
and land-based athletes.  While the land-based athletes only showed an upward trend compared to 
the sedentary group.  This may have been due to the authors including all land-based athletes into 
one group instead of separating them by type of sport, aerobic versus anaerobic.  Interestingly, the 
authors continued analyzing the swimmers and found those that competed for the national team, 
(i.e. the better swimmers) had superior FEV1 compared to the non-national swimmers.  When 
they controlled for years of training the difference was no longer apparent, suggesting the number 
of years trained has a significant impact on FEV1.  These articles provide evidence to show the 
positive influence long-term training provides to improving lung function. 
Conversely, despite all of the previously mentioned studies’ finding, significant positives 
in the impact of exercise training on pulmonary function there are many studies that oppose such 
findings.  Koch and Eriksson (41) used a 4-month period of endurance training in 11 to 13 year-
old children and found no significant differences in FVC and FEV1.  However, this study only 
had 9 participants who completed the study and did not utilize a control group to rule out effects 
from the boys’ maturation process.  Another study conducted by Hamilton and Andrew (35) 
focused on children aged 13-17 who played ice hockey.  Ventilatory tests were conducted before 
and after the 28-week hockey season.  Results were compared to age matched controls and 
showed no significant difference for any pulmonary measure.  However, they later suggest that 
the training the boys underwent may not have been rigorous enough to cause changes in lung 
function.  Additionally, Hulke and Phatak (38) utilized a 12-week 30 minutes daily of 
unsupervised, moderate intensity aerobic work.  Their results showed significant increases in 
PEF, but no other parameters significantly changed post exercise training.  The lack of 
improvements led them to believe the intensity and duration were not high enough to cause 
changes in FVC and FEV1.  The findings of the aforementioned studies demonstrate that with the 
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correct intensity, duration, and type of exercise improvements in pulmonary function are 
probable, particularly with long-term training. 
Importance of Lung Health 
The following studies support the importance of the pulmonary variables measured in the 
current study, as well as investigate the relationship between physical activity and its influence on 
long-term health and delaying lung aging.  In a study conducted by Pelkonen et al. (56) data on 
pulmonary function and physical activity was collected on 890 adult males for 25 years.  The 
authors concluded high levels of physical activity are associated with a slower decline in 
pulmonary function and a decrease in risk of mortality. Another study by Schunemann et al. (67) 
demonstrated that FEV1 is the most crucial variable when used as a long-term predictor for 
survival rates.  This was based on a 29-year follow up study of 554 men and 641 women.  The 
most complete study conducted by Nystead et al. (55) covered 8,047 subjects for 10 years, 
monitoring physical activity and lung function.  Their conclusion while similar went into more 
detail, stating regular physical activity corresponds to a reduction of 3-5 years of normal decline 
in FEV1.  Another variable crucial to measuring lung health is FVC, which is able to predict the 
compliance of lungs and the chest wall (20).  Together these create the FEV1/FVC ratio and in 
healthy adults this percentage should be greater than 70%.  Lastly, a decrease in PEF at hypoxia 
has shown a correlation with severity of acute mountain sickness (AMS) (60, 69).  These two 
studies found those with a significant drop in PEF compared to sea level suffered from the most 
severe cases of AMS.  Pollard et al. (60) explains this well, stating the AMS symptoms decrease 
the subject’s ability to produce a maximal expiration 
Effect of Altitude on Pulmonary Function 
 After covering the importance of physical trainings positive effect on lung function 
acutely and long-term, the following will focus on the influence of altitude on pulmonary 
function.  Reductions in airway resistance occur due to a decrease in air density, increasing the 
altitude only further increases the effect.  This has been known to increase maximal inspiratory 
11 
 
and expiratory flow rates (23).  As a result, FEV1 and PEF have generally been shown to increase 
(7, 23, 29, 47, 62), PEF more so than FEV1.  Forte Jr. et al. (23) demonstrated this in a study, of 
18 healthy young men at environmental altitude and hypobaric hypoxia (HH).  In both situations 
FEV1 significantly increased while PEF was not reported in this study.  Another study by Wolf et 
al. (61) found PEF to increase significantly after testing 21 healthy subjects at environmental 
altitude of 1,560 m.  On the other hand, FEV1 was not deemed significantly different, but showed 
an upward trend.  At an altitude of 3,457 m 9 subjects showed an increase in FEV1 and PEF in a 
study by Gautier et al. (29).  They attributed this to the changes in ventilatory rate due to a 
decrease in arterial partial pressure of oxygen (PO2) and decrease in airway resistance. 
 Conversely, FVC has generally been shown to decrease with exposure to hypoxic 
conditions (22, 23, 29, 47, 60).  Edward Schneider (65) noted a decrease in vital capacity in the 
early 1930s after studying mountaineers ascend Pikes Peak, CO.  He noted that the decrease in 
FVC  may be due to an enlargement of the pulmonary blood vessels that consequently occupy 
alveolar space normally available for air (17, 65).  Two other common concepts for the fall in  
FVC are respiratory muscle fatigue and subclinical pulmonary edema (47, 74).  More current 
studies by Forte Jr. (23) and Pollard (60) demonstrate further the decrease in FVC.  The study by 
Forte Jr. et al. (23) found significant decreases in FVC at an environmental altitude of 4,300 m 
and HH set to 4,200 m.  Pollard et al. (60) studied subjects at an even more extreme altitude of 
5,300 m at the Mount Everest base camp.  51 members of the British Mount Everest Medical 
expedition were studied using a hand held turbine spirometer as used in the current study.  Their 
results demonstrated a decrease in FVC, as well as an increase in PEF, but no change in FEV1.  
Furthermore, an early study conducted by Consolazio (7) et al. for U.S. Army Medical Research 
used 24 Army volunteers.  After traveling to an altitude of 4300 m, a decrease in FVC and 
increase in FEV1 in the soldiers was noted.  As shown by the information in studies reviewed the 
general consensus is a slight increase to change FEV1, a large increase in PEF, but a decrease in 
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FVC.  However, these results are still somewhat unexplained physiologically and not entirely 
agreed upon.  
Hypobaric versus Normobaric Hypoxia 
 Due to the majority of these studies utilizing environmental altitude, even less is known 
about the adaptions to HH or normobaric hypoxia (NH). The aim of both of these altitude 
simulations is to decrease the inspired partial pressure of oxygen (PiO2) either through a decrease 
in barometric pressure (HH) or a reduction in the fraction of inspired oxygen (FiO2) (NH).  Since 
the end result of both methods is a reduction of PiO2 either method should produce the same 
physiological response.  However, the literature commonly reports differences in all aspects 
including pulmonary function (46, 50, 64).  Savourey et al. (64) and Loppky et al. (46) both 
investigated the effects of NH and HH measuring various cardiopulmonary variables.  Authors 
from both studies had similar findings; respiratory rate increased, tidal volume decreased, and 
there was a reduction in ventilation during HH compared to NH.  The key difference as stated by 
Kayser (40), is that the lower pressure produced in HH leads to a lower air density, whereas NH 
just decreases the physical amount of O2 available.  Millet et al. (50) later concluded in their 
review article that HH is a more severe environmental condition, which causes different 
physiological adaptations compared to NH.  However, the differences in NH and HH are not 
completely agreed upon in the literature.  Mounier and Brugniaux (52) believe it all centered 
around the body sensing the amount of available oxygen and centers on the hypoxia-inducible 
factor-1 (HIF-1) transcription factor.  Further stating the differences in HH and NH are too small 
to be clinically relevant.  In the current study NH was used for training purposes due to the 
portability and practicality of use in military personal training.  While HH was used for pre and 
post testing due to the majority of literature agreeing that HH is a closer simulation of 
environmental altitude. 
Military Applications & Acclimatization 
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 The current study utilizes members from a Midwest University’s Reserve Officer’ 
Training Corps (ROTC) program.  Reasoning behind the choice of this population is due to the 
military’s current need to rapidly deploy soldiers in to mountainous regions (3, 42, 53).  Military 
duties commonly consist of lifting or carrying loads for long periods at submaximal intensities 
with quick periods of high intensity action (58).  These bouts of physically demanding work may 
result in a decline in performance due to fatigue or injury.  Consequently, adding altitude to the 
equation only exacerbates the issue.  Soldiers based at sea level typically experience a large 
decrease in aerobic endurance performance and only a slight to no decrease in anaerobic 
performance upon arriving to altitude (26).  AMS also commonly occurs to unacclimatized 
soldiers who ascend too quickly to high altitude, resulting in symptoms of headache, nausea, 
fatigue, and sleep disturbances, further reducing their ability to perform physical work (3).  A 
study by Hackett and Roach (34) found an astonishing 80% of individuals developed some 
symptoms of AMS within a few hours and reach peak severity at 36 hours.  Additionally, Fulco et 
al. (27) found that endurance performance can decrease 60% or greater at altitude compared to 
sea level.  Due to the high prevalence and severity of detriments a rapid acclimatization method 
would prove to be highly beneficial to the military.  
 Acclimatization is traditionally achieved by a slow progression, living a few days at 
various stages, gradually ascending to the desired altitude (26, 53).  However, this lengthy 
process defeats the purpose of the military being able to utilize a rapid response mission on short 
notice.  Therefore, various studies have investigated the effectiveness of using simulated 
intermittent altitude exposure prior to being deployed to high altitude regions (3, 5, 6, 26, 53, 66).  
Review articles by Muza (53), Fulco et al. (26), and Burtscher et al. (5) highlight the extensive 
scope of different methods authors have implemented to attempt rapid acclimatization, from 0.4 h 
to 16 h a day for 3 to 42 days at elevations ranging from 2250 m to 6000 m either utilizing 
exercise or at rest.  The various doses, level of altitude, and different types of simulated altitude 
make it difficult to compare the results of different studies.  Muza (53) closes his review stating 
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protocols utilizing altitudes greater than 4000 m and a duration greater than 1.5 h have a high 
probability of promoting altitude acclimatization, but studies under 4000 m and 1.5 h were not 
well documented and further research should be conducted in this area.  Fulco et al. (26) 
concluded that HH was more effective than NH for preacclimatization, however all NH studies 
included in this review used protocols where subjects were at rest or sleeping while using NH.  
Lastly, Burtscher et al. (5) concluded there is lack of studies to make a firm conclusion on 
recommendations using intermittent hypoxia for preacclimatization.  Authors also stated that 
longer protocols including exercise may further enhance endurance performance at altitude.  
 Finally, studies conducted by Schommer et al. (66), Dunfor et al. (18), Ventura et al. (73), 
Fulco et al. (20), and Debevec et al. (11) were found to have very similar methodologies to the 
current study.  Schommer et al. (66) randomly split 40 healthy volunteers, who then performed 4 
weeks of intermittent normobaric hypoxic training (INHT) or normoxic training (NT) using a 
bicycle ergometer.  INHT altitudes progressed from 2500 m to 3500 m over weeks 1-3 for a total 
of 9 h of training, while the last week was spent passively for 90 m sessions.  Once training was 
completed, subjects ascended to 3611 m for and overnight stay then proceeded to the peak at 
4559 m.  Testing for AMS and cardiopulmonary measures were conducted at both sites.  Results 
showed no significant differences at 4559 m, but AMS was significantly less prevalent in the 
INHT group compared to the NT group.  Due to the rarity of altitudes around 4559 m, the 
positive result at 3611 m would prove to be beneficial for the military. Dufour et al. (18) 
implemented a similar 6 weeks of INHT at 3,000 m, using varying intensities with 18 highly 
trained endurance athletes.  After training only the INHT group improved their VO2max 
significantly in normoxia and hypoxic conditions.  They attributed these improvements to muscle 
adaptations occurring during hypoxic training.  Further, Debevec et al. (9) and Ventura et al. (73) 
both utilized healthy males who performed 18 to 20 INHT sessions on a cycle ergometer.  
Debevec et al. pre and post-tested subjects at normoxia and HH similar to the current study, while 
Ventura et al. only tested at normoxia.  Both studies came to the same conclusion, INHT did not 
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significantly improve performance at sea level or HH compared to NT.  However, Ventura et al. 
implemented training sessions only 30 m long most likely resulting in an undertraining effect.  
Whereas, Debevec et al. trained subjects at 4500 m for 70 m a day, five days a week for 4 weeks 
straight.  This level of extreme altitude without sufficient rest between sessions may have resulted 
in overtraining or an inability for the subjects to perform maximally at post-testing.  Lastly, Fulco 
et al. (20) studied time-trial results for 6 healthy men after using NH for 6 straight days.  Two 
hours a day were spent at rest at 4500 m and 1 hour a day at 3000 m on a cycle ergometer.  
Interestingly, time trial performance improved significantly in hypoxic conditions, but not at 
normoxia.  These results are ideal for the military, as the protocol is quick (6 d) and effective for 
soldiers performing work at altitude.  The current study looks to build off the previously implied 
methods of INHT, furthering the research in the area. 
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CHAPTER III 
 
 
METHODOLOGY 
 
Participants 
Highly trained male members of the Oklahoma State University (OSU) Army or Air 
Force Reserve Officers’ Training Corps (ROTC) were solicited to participate in this study. Before 
participating, the study protocol, risks, and benefits were carefully explained to potential subjects.  
Participants gave their voluntary consent agreeing to participate in the protocol approved by the 
Oklahoma State University (OSU) Institutional Review Board (IRB).  Subjects were aged 
19.6±0.4 further, all anthropometric and physiological measures are shown in Table 1.  In the 
weeks before and throughout the study, subjects lived at an altitude just below 300 m above sea 
level.   
Prior to screening for eligible participants, all members of the Army and Air Force ROTC 
were presented protocol information, time required, risks, and benefits of the study.  Those who 
were interested were required to complete a maximal aerobic capacity treadmill test (VO2max) as 
a part of the pre-screening process.  A total of 191 cadets were informed of the study, of these 27 
responded with interest.  Of the initial 27, 20 participants were able to report for the VO2max test 
conducted in normoxic conditions (VO2-Npre).  Seventeen cadets exceeded the minimum fitness 
level and did not report any previous medical problems.  Two were excluded due an inability to 
achieve the required fitness level of a VO2max greater than 49.2 ml·min-1·kg-1 and one was  
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excluded due to a prior lower leg injury.  The 17 participants were then informed of their 
qualification for the study and scheduled for pre VO2max testing in hypobaric hypoxic (HH) 
conditions (VO2-Hpre).  Between the VO2-Npre and VO2-Hpre 5 cadets decided to no longer 
participate in the study, thus a total of 12 participants completed both Vo2-Npre and VO2-Hpre 
tests.  The remaining subjects were split into two groups experimental (EXP) n = 7 and control 
(CON) n = 5 via pair-wise selection, based on VO2-Npre scores.  Averages of 61.6 ml·min-1·kg-1  
(EXP) and 62.0 ml·min-1·kg-1 (CON) were determined to be not significantly different based on a 
t-test via SPSS (p > .05).  All additional anthropometric data and initial VO2max test scores are 
listed in Table 1.   No significance differences were found between groups for any measured 
variable.   
Experimental Design 
The study was organized into four stages, as illustrated in Figure 1. Pre-screening, pre-
testing in HH conditions, exercise training, and finally the post-testing.   
Pre-screening was completed in the laboratory under normoxic conditions.  Pre-screening 
consisted of completing a medical history questionnaire, assessments of body weight and height, 
and a VO2max test.  Criteria for inclusion consisted of a minimum VO2max of 49.2 ml·min-1·kg-1, 
no history of chronic obstructive pulmonary disease (COPD) or bronchial asthma (BA), and a 
non-smoker.  A VO2max score of 49.2 ml·min-1·kg-1 was chosen due the ACSM guidelines, 
stating 49.2 ml·min-1·kg-1is the minimum to be considered excellent amongst males of similar age 
(48).  If the minimum fitness requirement was met and there were no abnormities found in the 
medical questionnaire participants were scheduled for the next phase of testing. 
Pre-testing in HH conditions were performed in a hypobaric chamber adjusted to 
resemble approximately 3,048 m (10,000ft) above sea level.  Lung function assessments 
consisting of forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and peak 
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expiratory flow rate (PEF) were measured prior to the treadmill test with a portable spirometer. 
Also, the same VO2max test was performed but in HH conditions.  Peripheral capillary oxygen 
saturation (SpO2) was measured via a finger pulse oximeter before and after testing.   Due the 
acute exposure of hypoxia a board certified doctor of osteopathic medicine (D.O.) monitored 
participants closely while performing the VO2max test.  To support maximal effort, a minimum 
recovery of 48 h was allowed between the normoxic and HH VO2max tests.   
Prior to the first training session, baseline measures for normoxic conditions were 
recorded. These assessments included a spirometry test, heart rate (HR), SpO2, and a 7-site body 
fat measurement.  The exercise training spanned six weeks and involved three weekly sessions 
consisting of an hour each session.  A warm-up and cool down was integrated into the hour 
sessions, resulting in 18 hours as the maximum training time for each subject.  All training 
sessions were based on a percentage of their maximum HR (MHR) achieved in their respective 
VO2-pre-test.  For example, if assigned to the EXP group, training heart rates were based on the 
MHR achieved in theVO2-Hpre test, vice versa for the CON group.  Before beginning training 
each participant received their exercise prescription card and was briefed on the day’s workout.  
Subjects were allowed to control their own speed throughout training, but required to stay within 
the instructed HR range.  The treadmill grade remained constant at 2%.   
The first week served as an acclimatization period, where subjects walked/jogged at 50-
60% of MHR throughout the hour of training.  The second week increased the intensity to 60-
70% of MHR for 40 min, with a 10 min warm up and cool down at 50-60% MHR.  Weeks 3 and 
4 further increased the intensity to 70-77% of MHR, with the same warm up and cool down.  
Finally, weeks 5 and 6 consisted of subjects jogging 10 minutes at 60-70% Max HR, followed by 
20 minutes running at 78-85% MHR, then another 10 minutes at 60-70%, again with the same 
warm up and cool down.  This workout was performed so participants could become comfortable 
running at a moderately hard intensity, but preventing a maximal effort.  All participants were 
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required to have their training scheduled at least 24 hours apart for recovery purposes.  
Cardiopulmonary resuscitation (CPR) certified investigators supervised cadets throughout each 
training session.  
Post-testing involved the same VO2max test, spirometry, and pulse oximetry at normoxic 
and HH conditions.  The first post-test was separated by at least 48 hours from the final training 
session and again, the normoxic and HH tests were separated by 48 hours.  
Procedures 
Hypobaric Hypoxia Simulation 
The environmental conditions for normoxic and HH testing are illustrated in Table 5.  
The fraction of inspired oxygen (FiO2) remained constant at 20.9% throughout all pre and post- 
tests. However, normoxia averaged a barometric pressure of 744.0 mmHg, (PO2 - 155.5 mmHg), 
while the HH chamber was able to attain an average of 536.7 mmHg (PO2 - 112.7 mmHg). This 
is achieved by pumping air out of the airtight chamber until the chamber reached a pressure 
similar to an altitude of 3,048 m.  A hypobaric chamber technician was responsible for constantly 
maintaining and monitoring the pressure in the main chamber.  Prior to entering the hypobaric 
chamber each participant was instructed on the methods for clearing pressure from the ears via 
yawning or swallowing on the ascent and the Valsalva maneuver on the decent to ensure minimal 
pain.  To ensure each subject was exposed to the same acute dose of hypoxia, participants were 
brought up and taken down from HH individually accompanied by a registered nurse (RN), in a 
small, connected chamber. Two primary investigators and a D.O. remained inside the main 
chamber throughout the testing duration to conduct and closely supervise all testing.   
Spirometry 
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Lung function was measured following the standard testing procedures set by the 
American Thoracic Society (ATS) and European Respiratory Society (ERS) (49). The same 
portable spirometer, Contec SP10, was used in all pre and post-tests (Nature Spirit, Dallas, TX).  
Guidelines for recording an accurate FVC call for three different stages during the test, starting 
with a maximal inspiration, followed by a blast of exhalation, and exhalation is continued until 
the end of the test (EOT).  Emphasis was placed on the blast of exhalation, not holding the 
maximal inspiration too long, and continuing to exhale until the EOT.  All subjects were given 
detailed explanation and shown an example to make sure there procedures were fully understood.  
Each test was completed in a standing position with a nose clip in place and the subject holding 
the spirometer in one hand.  The investigator made certain the lips were sealed around the 
mouthpiece and provided verbal encouragement until the EOT criteria was met.  EOT criteria 
consisted of the participant exhaling for at least six seconds or the volume-time curve must have 
not shown any change for one second.  Every participant was given one practice test then was 
asked to record three acceptable spirograms.  To be considered acceptable the two largest values 
for FVC and FEV1 must be within 0.150L of each other.  The largest values were used for 
analysis.  In order to account for race, age, and height differences FVC and FEV1 was also 
interpreted into a percent predicted using the spirometric references presented by Hankinson et al. 
(37). 
Normoxic and HH Maximal Aerobic Capacity Tests  
VO2max tests were all conducted with a consistent protocol and under the same 
instructions.  Additionally, the same equipment, a Trackmaster motorized treadmill (TMX 425C, 
Newton, KS), TrueOne 2400 metabolic cart (Parvo Medics, Salt Lake City, UT), and Polar HR 
monitor (Polar Electro FT1 and T31, Lake Success, NY) was used throughout all testing to ensure 
reliable results.  The modified Astrand-Saltin protocol was used to achieve a true VO2max.  This 
protocol consisted of a 5-minute warm-up at treadmill speed of 9.7 km/h (6.0 mph) with a 0% 
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slope.  The initial testing stage began a 14.5 km/h (9.0 mph) with a 0% slope.  As the participant 
progressed, the speed remained constant, but the slope increased by 2% every two minutes until 
the subject experienced complete exhaustion.  Each participant was verbally encouraged 
throughout to give maximal effort.  Criteria for attaining a true VO2max was a respiratory 
exchange ratio greater than 1.10 or a MHR greater than 90% of their predicted MHR.  The 
expired gases were analyzed through the mixing chamber and reported using a 4 breath average.  
Calibration of the metabolic cart was performed with a 3-liter syringe and gas analyzers were 
calibrated according to the manufacture specifications.   
Intermittent Normobaric Hypoxic Training 
Training at normobaric hypoxia was achieved using Hypoxico (Hypoxico Altitude 
Training Systems (New York, NY) equipment which diluted the ambient air with nitrogen.  In a 
single blind approach, all participants were required to wear a High Altitude Training Mask 
(mask) throughout the training sessions.  However, only the subjects in the EXP group had their 
masks connected to the Everest Summit II Altitude Generator (altitude generator) breathing in 
hypoxic air.  Subjects in the control group were not connected to the altitude generator allowing 
them to exercise under normoxic conditions, but their masks were attached to a machine, an 
unused metabolic cart, to further resemble training in the INHT group.  This was an attempt to 
lessen the placebo effect and control for the effect of simply wearing a mask during training.  An 
altitude of 3,085 m (10,120 ft) was simulated during all INHT sessions for the EXP group.  To 
achieve this, the FiO2 of the inspired air was lowered to approximately 14.7% (PO2 - 155.5 
mmHg).  SpO2 was measured via an Oxi-Go finger pulse oximeter (Oximeter Plus, Inc., Roslyn, 
NY) before and after each VO2max test as well as the 50 m mark of training sessions for safety.  
HR was also monitored throughout all training so that the participant and investigator could 
monitor their effort level and safety. 
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Anthropometrics  
Body weight and height were measured during the pre-screening process using a Detecto 
Weigh Beam Eye-Level physician scale (Detecto Scale Company, Webb City, MO).  Body fat 
percentage was calculated following the American College of Sports Medicine (ASCM) guideline 
for a 7-site skinfold measurement (48).  Measurements were taken by the same investigator using 
a Lange Skinfold Caliper (Beta Technology Incorporated, Cambridge, MD) at the triceps, 
pectoral, midaxillary, subscapular, abdomen, suprailiac, and thigh locations and in that same 
order.  The investigator performed a minimum of two measurements at each site and the average 
of the two measurements was recorded.  A third measurement was taken if there was a difference 
greater than ± 1mm between the first and second measurements.   
Statistics 
Repeated measures analysis of variance (ANOVA) were used to measure between group 
(INHT versus normoxic training) and within group (pre and post-testing) effects.  A Newman 
Keuls post hoc test was used to determine the source of significant difference.  All other data 
were compared using a T-Test.  A value of p < 0.05 was considered statistically significant. 
Values are presented as means ± standard error (SE).  All statistical analyses were performed 
using SPSS version 21.0. 
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Figure 1.  Study design 
 
Complete study design, including training program.  Training percentages are based on maximum 
heart rate archived during respective VO2-pre-test.  WU = Warm Up, CD = Cool Down, always at 
50-60% of maximum heart rate.  
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Figure 2.  Subject Participation 
 
Flowchart describing participants, from recruiting to our final subjects who completed the entire 
study.
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CHAPTER IV 
 
 
FINDINGS 
 
The purpose of this study was to determine the effects of aerobic INHT for 6 weeks, 
investigating VO2max and pulmonary function at normoxia and HH.  Of the 12 subjects who 
started, final participant count after two pre-tests, 6 weeks of training, and two post-tests was 10 
(EXP = 6, CON = 4) male ROTC members.  Age, baseline VO2max, and all other anthropometric 
information is listed in Table 1, none of these parameters different significantly between groups.  
The EXP and CON groups completed an average of 16 and 17 sessions respectively, out of the 
maximum 18.  There were no adverse events, complaints of injury, or severe discomfort during 
all training sessions.  Over the 6 weeks the EXP group covered an average distance of 95.9 km 
(59.6 miles) per person, ran at an average pace of 10:00 min/km, climbed 10,129.8 m, and 
recorded an average SpO2 of 82.4% throughout training.  Whereas the CON group averaged a 
total of 109.7 km (68.2 miles) per person, average pace was 9:17 min/km, climbed 11,552.8 m, 
and average SpO2 was 97.2.  Weekly averages and all other training information are listed in 
Table 2. 
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Table1.  Anthropometrics and maximum oxygen uptake 
Values are means ± SE.  VO2max in ml·min-1·kg-1.  NS = p > 0.05.   
 
Table 2.  Training Sessions 
  Week 1 
Per Session 
Week 2 
Per Session 
Weeks 3 & 4 
Per Session 
Weeks 5 & 6 
Per Session 
Total 
Per Person 
Distance 
Covered 
(km) 
E 5.13 5.76 6.30 6.22 95.9 
C 5.08 6.23 6.71 6.79 109.7 
SpO2 
(50 min) 
E 84.8 82.4 82.3 84.2 82.4 
C 97.1 96.9 97.1 97.5 97.2 
Average 
Pace 
(min/km) 
E 11:41 10:25 9:31 9:40 10:00 
C 11:49 9:38 8:57 8:50 9:17 
Meters 
Climbed 
(m) 
E 541.7 608.6 665.4 656.8 10,129.8 
C 536.6 657.8 708.1 716.8 11,552.8 
Average 16 sessions per person for EXP and 17 sessions per person for CON out of a possible 18. 
E = experimental group, C = control group. 
 
VO2max Tests 
When both EXP and CON groups were combined, a t-test showed a significant increase 
in VO2max from pre to post-testing in both conditions, normoxia and HH.  VO2max in normoxia 
improved from 61.7±1.8 ml·min-1·kg-1 to 65.0±1.7 ml·min-1·kg-1 (p = 0.031) while, in HH 
VO2max improved from 35.9±1.5 ml·min-1·kg-1 to 39.6±1.3 ml·min-1·kg-1 (p = 0.005) (Fig. 3 & 
 INHT Group (EXP) NT Group (CON) Significance 
Number of Subjects, n 6 4  
Age, yr 20.2±0.3 19.0±1.0 NS 
Height, cm 176.4±2.3 181.9±2.3 NS 
Body Weight, kg 73.5±2.2 81.8±5.5 NS 
Body Fat, % 9.4±1.5 9.3±1.5 NS 
Normoxic VO2max 61.6±2.5 62.0±3.0 NS 
Hypoxic VO2max 34.7±1.9 37.7±2.3 NS 
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Table 3).  When splitting the total population into their respective EXP and CON groups there 
were no significant differences seen between pre and post VO2max measures (Table 3).  
However, the EXP group did improve an average of 4.5% at normoxia and 15.5% at HH, while 
the CON group improved 7.3% at normoxia and 4.2% at HH.  The percent increase after training 
in the EXP group of 15.5% at HH was found to be a significant increase when compared to the 
CON group (p=0.046). Altitude did have a significant impact on VO2max scores (p < 0.001), 
demonstrating a 40.4% decrease at HH compared to normoxia.  In addition to VO2max, 
maximum heart rate and SpO2 are listed in table 4.  Environmental conditions such as, 
temperature, percent humidity, and barometric pressure are listed in table 5. 
Table 3. VO2max Measures 
Values are means ± SE.  VO2max in ml·min-1·kg-1.  * = p < 0.05 when comparing total pre-test to 
post-test.  ** = p < 0.05 when comparing % increase between EXP and CON group. 
Figure 3. VO2max 
   
Values are means ± SE.  * = p < 0.05 when comparing total pre-test to post-test. 
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 Pre Post % Increase Pre Post % Increase 
EXP 61.6±2.5 64.0±2.2 4.5±3.2 34.7±1.9 39.9±1.2 15.5±4.2 ** 
CON 62.0±3.0 66.6±2.7 7.3±1.8 37.7±2.3 39.2±1.9 4.2±1.8 
Total 61.7±1.8 65.0±1.7* 5.6±2.0 35.9±1.5 39.6±1.3* 11.0±3.1 
* 
* 
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Table 4. Maximum Heart Rate and SpO2 
Values are means ± SE. 
Table 5. Environmental Conditions 
Pre/ Post Test & Oxygen 
Concentration 
Barometric Pressure, 
mmHg 
Temperature, C˚ Humidity, % 
Pre-Test Normoxic 744.0 22.5 42.2 
Pre-Test HH 537.2 26.0 54.9 
Post-Test Normoxic 744.0 22.0 31.3 
Post-Test HH 536.2 24.0 22.5 
Values are means. 
 
Pulmonary Function Tests 
Table 6 and 7, as well as figure 4 show pulmonary function results taken with the 
spirometer. The combined results of the EXP and CON groups pre and post-tests were evaluated 
to compare the effect of altitude versus normoxia.  Starting with FVC, when combined there was 
a significant decrease in FVC at HH compared to normoxia (p = 0.037).  In addition, when body 
size was accounted for FVC% also showed a significant decrease at HH (p = 0.040) compared to 
normoxia.  FEV1 and FEV1% showed no significant change, however PEF demonstrated a 
significant increase at HH compared to normoxia (p = 0.001).  Due to the decrease in FVC there 
was also a significant increase in the FEV1/ FVC ratio at HH when compared to normoxia (p = 
0.017).  
Once measures were split into separate EXP and CON groups for pre and post-tests there 
were significant differences in 3 of the 6 variables.  FVC showed significant differences within 
the EXP group due to testing at normoxia compared to HH.  The pre-test at normoxia was 
 Heart Rate SpO2 
 Normoxia HH Normoxia HH 
 Pre Post Pre Post Resting Pre Post 
EXP 199.5±1.3 196.8±3.1 193.7±2.6 187.0±3.5 98.6±0.3 90.7±0.5 92.8±0.3 
CON 192.3±1.7 192.0±3.8 182.0±3.2 184.5±4.2 98.3±0.3 92.0±0.6 88.9±0.4 
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significantly higher than the pre-test at HH (p = 0.041) and the post-test at HH (p = 0.016).  
Further, the post-test at normoxia was also significantly higher than the pre-test at HH (p = 0.004) 
and the post-test at HH (p = 0.001).  FVC% results displayed a significant decrease in the EXP 
group from the normoxic pre-test to hypoxic post-test (p = 0.032), along with the post-test at 
normoxia to pre-testing at HH (p = 0.009) and post-testing at HH (p = 0.001).  Additionally, in 
the CON group there was a significant decrease from the pre-test at HH to the post-test at HH.  
Lastly, FEV1/FVC increased significantly in the EXP group from the pre-test at normoxia to the 
pre-test at HH (p = 0.006) and the post-test at HH (p = 0.004).  In the CON group there was a 
significant increase from the pre-test at normoxia to the post-test at normoxia.  No other 
measures, including FEV1, PEF, and FEV1%, for the EXP or CON group differed significantly 
when comparing pre-test to post-test within or between groups. 
Table 6.  Spirometry Measures  
  EXP Group CON Group 
  Pre Post Pre Post 
FVC, L N 4.99±0.3 5.07±0.3 5.01±0.4 5.10±0.4 
HH 4.89±0.3** 4.85±0.3** 5.14±0.3 5.00±0.4 
FEV1, L N 4.16±0.3 4.28±0.3 4.27±0.2 4.53±0.3 
HH 4.27±0.3 4.25±0.3 4.47±0.2 4.37±0.3 
PEF, L/s N 8.92±0.7 9.27±0.6 9.63±0.8 10.38±0.8 
HH 9.58±0.7 10.25±0.8 10.80±0.9 11.41±0.9 
FEV1/FVC N 83.1±0.9 84.4±1.0 85.3±1.1 88.8±1.3* 
HH 87.1±1.2** 87.5±0.8 86.8±1.5 87.2±1.0 
FVC, % N 90.8±3.0 92.2±2.9 89.5±3.7 91.9±3.1 
HH 89.0±2.6 88.1±2.8** 91.2±3.5 89.5±3.4* 
FEV1, % N 89.8±4.6 92.5±4.8 91.1±5.6 96.8±5.9 
HH 92.2±4.7 91.8±4.7 95.5±5.7 93.4±5.8 
Values are means ± SE.  N = normoxia, HH = hypobaric hypoxia.  * = p < 0.05 when comparing 
within group pre-test and post-test.  ** = p < 0.05 when comparing within group normoxia versus 
HH.   
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Table 7.  Study Total Pulmonary Function 
 Normoxia HH p-Value 
FVC, L 5.04±0.2 4.95±0.1 0.037* 
FEV1, L 4.29±0.1 4.32±0.1 0.465 
PEF, L/s 9.50±0.4 10.39±0.4 0.001* 
FEV1/FVC 85.1±0.9 87.2±0.8 0.017* 
FVC, % 91.0±2.2 89.4±2.0 0.040* 
FEV1, % 92.2±2.4 93.0±2.4 0.461 
Values are means ± SE.  * = p < 0.05 when comparing study totals at normoxia versus HH. 
Figure 4. Pulmonary Function Pre-test versus Post-test & Normoxia versus HH 
 
 
Values are means ± SE.  * = p < 0.05 when comparing study totals at Normoxia versus HH.  A = 
FVC, B = FEV1, C = PEF.
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CHAPTER V 
 
 
CONCLUSION 
Training & VO2max 
 Six weeks of INHT integrated into ROTC members normal physical training did not 
elicit any greater improvements when compared to the NT group in VO2max or pulmonary 
function measures after testing in normoxic and HH conditions.  Although, when percent increase 
in VO2max was analyzed there was a significant improvement at HH in the INHT group 
compared to the NT group.  Further, when groups were combined there was a significant increase 
in VO2max from pre to post-testing at normoxia and HH, demonstrating the training methods 
were effective in improving fitness.  When comparing the EXP and CON groups overall training 
distances, pace, and SpO2 major differences can be noted.  Overall the CON group covered 
14.4% more distance and trained at a pace 43 seconds faster, but maintained an average SpO2 of 
97.2 compared to the EXP group average of 82.4.  These differences are in part due to the way 
training intensities were established.  Running based on MHR was implemented so each group 
would see an equal relative workload.  However, while the heart was accounted for the lungs and 
skeletal muscle may have seen different workloads between groups.  Interestingly, in the CON 
group an increase of 7.3% was seen in normoxic VO2max compared to 4.5% in the EXP group.  
This difference may have been due to the CON group experiencing a greater absolute workload, 
increasing their fitness to a greater extent.  In contrast, the EXP group while training at a lower 
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absolute workload was adjusting to running while breathing in hypoxic air and exercising with 
greatly decreased SpO2 levels.   These training adaptations may have been responsible for the 
15.5% increase in VO2max at HH compared to 4.2% in the CON group. 
Our results are consistent with the Fulco et al. (28) study that found INHT improved time 
trial performance at hypoxia, but not in normoxia.  However, their study only included 6 subjects 
and was able to achieve these results in only 6 days, but lacked a control group.  Furthermore, 
when looking at percent increase after training, our results are similar to a study by Geiser et al. 
(30).  Their study utilized the same method of INHT at an altitude of 3850 m, but used two 
different training intensities within the INHT and NT groups.  After 6 weeks of training the INHT 
groups, both high intensity and low intensity, demonstrated a 7.2 % VO2max improvement in 
hypoxia, compared to around a 3.0% increase in the NT groups.  On the other hand, all four 
groups improved around 3.5% when tested in normoxia.  In addition, Dufour et al. (18) noted an 
increase in VO2max at hypoxia with the INHT group compared to the NT group, but also saw a 
similar increase in normoxia.  The authors did not attribute these improvements to an increase in 
the oxygen carrying capabilities of the blood, but rather beneficial adaptations at a muscular level.  
In contrast, when only looking at the lack of significant between group and within group results 
our study is in agreement with Debevec et al. (11) and Ventura et al. (73).  Their studies both 
found a lack of significant improvements due INHT, however Debevec et al. shows similar trends 
to the current study.  As the NT group improved to a greater extent when tested in normoxia, 
while the INHT group showed greater improvements in hypoxic conditions.  Ventura et al. did 
not show improvements in either group, but this may have been due to a lack of time training in 
hypoxia, as their training total only included 9 hrs over 6 weeks.  Since the current study did not 
involve blood testing, we conclude the improvement is due to adaptations of the skeletal muscle.  
In detail, training in hypoxic conditions may cause transformations within skeletal muscle, 
allowing the muscle to be more efficient at utilizing limited amounts oxygen (18, 30, 61). 
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Mechanical Pulmonary Function Changes 
There were no significant pre to post-test differences in FVC, FEV1, or PEF due to either 
INHT or NT.  These findings are in disagreement with Nourrey et al. (54) and Fatima et al. (20), 
yet major differences are seen in study populations from the current study compared to these 
studies.  Nourrey et al. (54) investigated training effects in 24 children.  Since the children are 
still growing their lungs may have more plasticity for adjusting to the stressors of exercise 
training.  Fatima et al. (20) used a much larger population of 292 subjects and stated some 
variability in their results was due to lack of effort during spirometry.  A spirometry test is 
completely user dependent and it is important each subject is motivated to give maximal effort.  
Hulke et al. (39) and Thaman et al. (71) also noted significant changes in pulmonary function, but 
were able to use much longer study designs of 20 weeks and 9 months, respectively.  Due to their 
findings, along with positive findings from other previous studies analyzing the long term effects 
of training on pulmonary function, led us to believe our study did not have a long enough 
duration to cause mechanical changes within the pulmonary system.  Further strengthening this 
suggestion are the findings of Debevec’s (10) study that found no differences in FVC, FEV1, and 
PEF after 4 weeks of rigorous aerobic training. 
Hypoxia versus Normoxia 
  Hypoxic testing conditions did cause a significant decline in VO2max, FVC, and 
FVC%, while causing an increase in FEV1/FVC and PEF in comparison to normoxia.  The 
average decline of 40% in VO2max was greater than initially expected.  However, studies by 
Lawler et al. (43) and Ferretti et al. (21) were able to demonstrate that highly trained individuals, 
such as the subjects in our study, demonstrated a greater loss in VO2max when exposed to acute 
hypoxia, compared to untrained individuals.  Dempsey et al. (13) alluded to the mechanisms that 
may be responsible for this variability in loss of performance at altitude.  Their estimation was a 
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reduction of 5 to 10% for every 304.8 m, based on their concept in which trained endurance 
athletes are already pushing their respiratory systems towards failure.  Therefore, when altitude 
becomes a factor performance suffers to a greater extent.  Whereas, an untrained subject is not 
stressing the limits of their respiratory system, so altitude does not have as large of an impact.  
Further, the authors declare the hyperventilatory response to hypoxia leads to increased work for 
the respiratory muscles leading to fatigue. 
Fatigue and an increase in workload for respiratory muscles has been reported as a 
possible  method to explain the decrease in FVC, which was reported in the current study as well 
as many other studies (22, 23, 47, 60, 65).  Another possible explanation for this decrease as 
stated by Drinker et al. (17), is an enlargement of pulmonary blood vessels.  Further supporting 
this explanation, Welsh et al. (74) noted an acute decrease in FVC after hypoxic exposure that 
resolved slowly after 48 hours.  They also attributed the fall in FVC to an increase in pulmonary 
blood volume, which slowly decreased over time.  Providing other alternative explanations, 
Mason et al. (47) reported a decrease in FVC, no change in FEV1, and an increase in PEF during 
an ascent to 5300m.  They proposed a reduction of inspiratory force, subclinical pulmonary 
edema, increase in pulmonary blood flow, or changes in airway closure were four possible 
methods causing the decline in FVC.  The authors concluded that multiple factors may play a role 
in the decrease of FVC but the main factor is subclinical pulmonary edema.  Due to the increase 
in PEF, muscular fatigue is unlikely to be the main cause, unless measures were taken post 
exercise.  Subsequently, the current study lacks a chest x-ray or measures of pulmonary blood 
flow, therefore we are unable to build further on the other two proposed concepts.   
 Our outcome on FEV1 of no significant change, but a slight increase at HH is also in 
agreement with most current studies (7, 29, 47, 60, 75).  Forte Jr. et al. (23) was able to report a 
significant increase in FEV1, but was surprised by this finding and proposed no reasoning behind 
the increase.  Authors were much more in agreement with the general findings of the literature, 
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stating FEV1 measures are relatively insensitive to altitude.  Since FEV1 is the flow of the first 
second, it benefits from the higher PEF, however the later part is influenced by the same 
mechanisms that affect FVC.  Due to FEV1 being a combination of the two, a slight increase to no 
change at altitude is largely agreed upon throughout the literature. 
 As in this study, the common findings of PEF are a significant increase when at altitude 
(22, 23, 29, 47, 60, 75).  The increase in PEF is due to the changes in gas density because of the 
decrease in barometric pressure.  Dawson and Elliot (9) were able to come up with a formula to 
predict PEF change based on the difference in barometric pressure : PEF = √(SLBP/ABP).  SLBP 
represents the sea-level barometric pressure and ABP is the barometric pressure at altitude.  
However, it has been found this formula only works in ideal, identical conditions at sea-level and 
altitude.  In actual mountain ascent situations there is typically a decrease in temperature as the 
environment normally becomes much colder with an increase in altitude.  The cold environment 
causes an increase in airway obstruction that may counteract the reduction in gas density.  
Despite, environmental factors, PEF remains highly agreed upon throughout numerous studies 
and is the only predictable variable tested. 
Military Applications 
 The current study revealed encouraging results for the implication of INHT training into 
normal military training.  While mostly ineffective at sea-level, increased endurance at altitude 
would be very beneficial for quick personal deployment into a high altitude region.  Due to the 
increased effort required to exercise in hypoxic conditions care must be taken not to overtrain 
participants.  This was the reasoning behind our 6 week training plan.  By using low intensities 
the first two weeks participants were able to become accustomed to the mask and decrease in 
available oxygen.  However, undertraining is just as ineffective, therefore at weeks 3 and 5 
intensity was increased.  We believe this method of slowly building up training intensity is more 
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effective than setting one intensity for the entire training period as seen in other studies (11, 73).  
Further supporting this model are the positive results from the study by Dufour et al. (18), which 
also increased intensities midway through training.  Additionally, care must be taken not to 
interfere or reduce their normal training load outside of INHT.  Modifying all training just before 
being deployed may cause more detrimental outcomes rather than benefits.  It is important to 
remember this is supplemental training not the centerpiece.  
 While spirometry measures proved to be unaffected by 6 weeks of training under either 
training conditions, differences at simulated altitude compared to sea-level may be beneficial for 
evaluating AMS and acclimatization.  As reported, FVC and PEF were significantly affected by 
the change from sea-level to simulated altitude.  Multiple studies have found a significant 
correlation between AMS symptoms and decreased PEF scores (60, 69).  This was explained by 
Pollard et al. (60) as a reduction of effort due to the symptoms that occur  with AMS.  Thus, a 
quick spirometric measure may be able to detect the severity of AMS an individual is 
experiencing.  Furthermore, considering one of the main reasons FVC is decreased at altitude is 
thought to be subclinical pulmonary edema, hence FVC may be more beneficial at detecting 
AMS or HAPE.  This is backed by findings from the study by Fischer et al. (22), where one of 
their subjects suffered from HAPE.  The subject showed a 51% reduction of FVC from baseline 
when suffering from HAPE, however after residing in low altitude for two days HAPE 
normalized and FVC increased to 95% of baseline.  This is only one case, but due to the severity 
of HAPE and the simplicity of spirometry, a reduction of FVC may serve as an early indicator for 
impending pulmonary edema.  Further support for this concept are results from a study by Welsh 
et al. (74) that found FVC returns to near normal levels after 48-72 hrs at altitude.   
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Limitations and Future Studies 
 A major limitation is the lack of participants completing the study, which greatly reduces 
the statistical power.  While there was an abundant number initially willing to participate, once 
they learned of the time commitment many dropped out of the study despite being interested.  
Although it was only three hours a week, our population of current students participating in 
ROTC were likely to already have full schedules.  The other studies similar to ours were able to 
have anywhere from 12 to 18 subjects (11, 18, 73).  Future studies, as hard as it may be, must aim 
for 18-20 subjects in order to detect changes with greater precision.   
 This study was the first of our knowledge to incorporate a sham treatment, allowing both 
groups to train while wearing masks and completely unaware of which condition they were in.  
Wearing a mask while training can be awkward, uncomfortable, and may restrict breathing.  
Therefore, accounting for this we felt this eliminated an important confounding variable.  
Additionally, this was able to limit any placebo effect the participants may have felt.  Future 
studies should implement similar methods in order to control for these dissimilarities, increasing 
the probability that changes in measured variables were caused by INHT alone.  
 Future studies focusing on changes to FVC and PEF after being exposed to altitude are 
needed to determine the process of pulmonary acclimatization.  Studies would need to be longer 
in duration in order to track the time at which FVC approaches baseline measures.  However, if 
there is strong correlation, spirometry may be a quick way to estimate ones level of 
acclimatization and risk for adverse symptoms.   
Conclusions 
 The results of the current study showed that an INHT protocol of varying intensities 
spanning 6 weeks was able to provide a significant percent increase in VO2max for the EXP 
group at HH, but not at normoxia.  However, spirometric measures were unaffected by either 
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training method at HH or normoxia.  FVC and PEF were affected by the change from sea-level to 
simulated altitude, possibly proving to be beneficial in detecting early indications of AMS or 
HAPE.  The present study was also able to provide an effective training design for introducing 
INHT into regularly scheduled outside physical training.  Lastly, a unique method in limiting the 
difference in opposing experimental groups was carried out, by suggesting that all subjects wear 
masks while training.
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Dear Potential Participant, 
 
My colleagues and I are currently interested in investigating the effects of intermittent hypoxic 
training on hypobaric performance. In other words, we are interested in learning about the 
efficacy of simulated altitude exercise training on aerobic performance at altitude. We are doing 
so with the hope of gaining more insight in this area in order to assist those responsible for the 
physical training programs in the U.S. Armed Forces.  
This study will involve the completion of the following testing procedures: 
 Once you have read through and signed the informed consent document you will be 
asked to schedule a day to begin the study. Once you provide your consent you will be 
scheduled to participate.  
 
 Depending on the group you are randomly selected to participate in, you will be asked to 
attend testing on either four or five separate days, the pre-assessment testing days, the  
 
 Post-assessment testing days approximately 6 weeks following the initial testing day, and 
if you are selected to participate in the experimental group, the final testing day 
approximately 2 weeks following the post-assessment testing day.  
On the first day of both the pre- and post-assessment testing days you will be asked to complete 
the following at the OSU Health & Human Performance Laboratory located in the Colvin 
Recreation Center: 
 Complete height, weight, and body composition (7-site skinfold) testing 
 Complete a 5 minute warm-up on a stationary bicycle 
 Complete a spirometry test. 
 Complete a maximal oxygen uptake (VO2max) treadmill test. This test consist of 2-
minute stages with increases in intensity every stage until exhaustion is reached and the 
participant ends the test. 
 Complete fingertip point-of-care (POC) blood lactate measurements immediately and 5 
min after completion of VO2max test 
 Complete a blood draw performed by an Oklahoma State University Health Sciences 
Center medical professional 
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On the second day of both the pre- and post-assessment testing days you will be asked to 
complete the following at the Oklahoma State University Center for Health Sciences Center for 
Aerospace and Hyperbaric Medicine: 
 Complete a 5 minute warm-up on a stationary bicycle 
 Complete a spirometry test. 
 Complete a maximal oxygen uptake (VO2max) treadmill test in a simulated altitude 
chamber. This test consist of 2-minute stages with increases in intensity every stage until 
exhaustion is reached and the participant ends the test. 
 Complete fingertip point-of-care (POC) blood lactate measurements immediately and 5 
min after completion of VO2max test 
 
On the fifth testing day, which will only apply if you are selected to participate in the 
experimental training group, you will be asked to complete the following at the Oklahoma State 
University Center for Health Sciences Center for Aerospace and Hyperbaric Medicine: 
 Complete a blood draw performed by an Oklahoma State University Health Sciences 
Center medical professional 
 Complete a 5 minute warm-up on a stationary bicycle 
 Complete a spirometry test. 
 Complete a maximal oxygen uptake (VO2max) treadmill test in a simulated altitude 
chamber. This test consist of 2-minute stages with increases in intensity every stage until 
exhaustion is reached and the participant ends the test. 
 Complete fingertip point-of-care (POC) blood lactate measurements immediately and 5 
min after completion of VO2max test 
If you decide to participate, and you complete all phases of this research study, you will be 
compensated in the amount of $100. If you are willing to participate in the aforementioned study, 
please email me indicating your willingness to participate.  
Thank you in advance for your time. 
Sincerely,  
John Sellers    Taylor Monaghan 
(918) 625-9945    (918) 520-8954 
john.sellers@okstate.edu  taylor.monaghan@okstate.edu 
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RESEARCH PARTICIPANT CONSENT FORM 
Project Title: The effects of normobaric hypoxic training on hypobaric performance. 
Investigators: John Sellers, Health & Human Performance, Oklahoma State University 
 Taylor Monaghan, Health & Human Performance, Oklahoma State University 
 Dr. Bert Jacobson, Health & Human Performance, Oklahoma State University 
Purpose: 
The primary aim of the research project will be to determine the efficacy to improve maximal 
aerobic capacity in well-trained individuals in a hypobaric hypoxia setting using normobaric 
hypoxia intermittent hypoxia training (IHT). A secondary aim of this investigation will be to 
determine if the proposed intervention protocol (6 wk x 1 hr x 3 d per week) is sufficient to elicit 
significant changes in the oxygen carrying capacity measures in the blood. Another purpose of 
this study will be to determine if significant changes in body composition as evaluated through 
skinfold measurements occur as a result of IHT when compared to the control group. 
Procedures: 
The tasks required if you volunteer for this study are to: 
 Once you have read through and sign this informed consent document you will be 
scheduled to participate.  
Upon granting consent to participate in this study, you will perform the initial base-line testing. 
Testing will take place in either the Applied Musculoskeletal and Human Physiology Research 
Laboratory in 192 Colvin Recreation Center at Oklahoma State University or the Oklahoma State 
University Center for Health Sciences Center for Aerospace and Hyperbaric Medicine. As part of 
the pre-screening process, you will complete the following: 
 Height and weight measurements 
 A 7-site skinfold measurement test to analyze body composition  
 A blood draw performed by an Oklahoma State University Health Sciences Center 
medical professional  
 Complete a spirometry test. 
 Complete a maximal oxygen uptake treadmill test (aka VO2max test). This test consist 
of 2-minute stages with increases in intensity every stage until exhaustion is reached and 
the participant ends the test 
 Complete fingertip point-of-care (POC) blood lactate measurements immediately and 5 
min after completion of VO2max test 
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o In order to be considered for continued participation in the study, participants 
will have achieved a VO2max of at least 49.2 ml/kg/min. As there is a minimum 
fitness standard that must be met prior to participation in the training 
intervention, it is possible that you will complete the first day of pre-testing at 
the Applied Musculoskeletal and Human Physiology Research Laboratory and 
will not meet the minimum standards and will thus no further participation will 
be asked of you. If you meet the VO2max requirement from the initial pre-tests, 
you will then perform the same VO2 treadmill test in an altitude chamber at the 
Oklahoma State University Center for Health Sciences Center for Aerospace and 
Hyperbaric Medicine. If selected for participation, you will be asked to maintain 
your current dietary and sleeping habits as well as complete weekly physical 
activity logs. 
Upon selection to this study, you will then perform a treadmill ergometer training protocol, with 
the control group performing the training sessions in a normoxic (normal partial pressure of 
Oxygen in the air) setting and the experimental group will perform all training sessions in 
normobaric hypoxia (simulated altitude of 3,000 m). The training intervention will be 6 weeks in 
duration, with 3 1-hr training sessions per week. Each training session for all participants will 
consist of a 10-min warm-up at approximately 50% of the participant’s pre-screening VO2max, a 
40-min interval workout between 60-80% of the participant’s pre-screening VO2max, and a 10-
min cool-down at approximately 40-50% of the participant’s pre-screening VO2max. There will 
be a 24-48 hr recovery period between each training session. All training sessions will take place 
in the Oklahoma State University Applied Musculoskeletal and Human Physiology Research 
Laboratory in 192 Colvin Recreation Center under the supervision of the primary investigator or 
other OSU Health & Human Performance graduate assistants who have completed the necessary 
CITI Responsible Conduct of Research Training. 
Upon the completion of the 6-wk intervention period, you will perform post-testing assessments. 
Post-testing will take place in either the Applied Musculoskeletal and Human Physiology 
Research Laboratory in 192 Colvin Recreation Center at Oklahoma State University or the 
Oklahoma State University Center for Health Sciences Center for Aerospace and Hyperbaric 
Medicine. As part of the post-testing process, you will complete the following: 
 Weight measurement 
 A 7-site skinfold measurement test to analyze body composition  
 A blood draw performed by an Oklahoma State University Health Sciences Center 
medical professional 
 Complete a spirometry test. 
 Complete a maximal oxygen uptake treadmill test (aka VO2max test) in both the 
Oklahoma State University Applied Musculoskeletal and Human Physiology Research 
Laboratory in 192 Colvin Recreation Center and the altitude chamber at the Oklahoma 
State University Center for Health Sciences Center for Aerospace and Hyperbaric 
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Medicine. This test consist of 2-minute stages with increases in intensity every stage 
until exhaustion is reached and the participant ends the test. 
 Complete fingertip point-of-care (POC) blood lactate measurements immediately and 5 
min after completion of VO2max test 
If you are selected to participate in the experimental training group, you will be asked to return 
approximately two weeks after the completion of the post-testing sessions. During this fifth and 
final testing day, you will be asked to complete the following: 
 A blood draw performed by an Oklahoma State University Health Sciences Center 
medical professional 
 Complete a spirometry test. 
 Complete a maximal oxygen uptake treadmill test (aka VO2max test) in the altitude 
chamber at the Oklahoma State University Center for Health Sciences Center for 
Aerospace and Hyperbaric Medicine. This test consist of 2-minute stages with increases 
in intensity every stage until exhaustion is reached and the participant ends the test. 
 Complete fingertip point-of-care (POC) blood lactate measurements immediately and 5 
min after completion of VO2max test 
Risks of Participation: 
As this study will be utilizing highly-trained individuals, the risks associated with the study are 
minimal and with no greater physical demands than your current exercise program. In case of 
injury or illness resulting from this study, emergency medical treatment will be available; 
responders are CPR – 1st responder certified along with access to 911 will be available. No funds 
have been set aside by Oklahoma State University to compensate you in the event of illness or 
injury. 
Benefits: 
Participants will benefit from being able to see if increases in aerobic capacity occur as a result of 
completing 6 weeks of intermittent hypoxic training. Participants will also be compensated in the 
amount of $100 if they complete all phases of this study. 
Confidentiality: 
Due to multiple testing sessions to be completed during various times over more than 2  months, 
all testing results will be tracked by a random subject ID number issued to each participant. The 
subject ID number will only be known by the primary investigator and the respective participant. 
Upon completion of the testing period subject ID numbers will be destroyed immediately. Only 
aggregate data will be reported. Aside from the original data all references will only contain 
subject ID number references as each participant will be assigned an ID number. We are 
interested in reporting data reflective of how the group(s) as a whole responded to the 
intervention program. Only aggregate data will be published. No individual data will be 
51 
 
published. Testing results will not be shared with supervisors of any nature. Research records will 
be stored securely for 3 years and only researchers and individuals responsible for research 
oversight will have access to the records. These forms will be kept in a locked file cabinet in the 
Applied Musculoskeletal and Human Physiology Laboratory which only the researchers will have 
access to. The signed consent forms will be kept for 3 years after the research is complete per 
federal guidelines. 
Compensation: 
Financial compensation in the amount of $100.00 will be provided to each participant that 
completes all phases of this research study; further, individual results of the study can be obtained 
by all participants following analysis by contacting John Sellers at john.sellers@okstate.edu. 
Contacts: 
If you need additional information concerning the study contact advisor Dr. Bert Jacobson, 101 
CRC, Oklahoma State University, Stillwater, OK 74078, 405-744-2025, 
bert.jacobson@okstate.edu, or John Sellers, 192 CRC, Oklahoma State University, Stillwater, OK 
74078, 405-744-9373, john.sellers@okstate.edu. 
If you should have questions about your rights as a research volunteer, you may contact Dr. Hugh 
Crethar, IRB Chair, 223 Scott Hall, Oklahoma State University, Stillwater, OK 74078, 405-744-
3377 or irb@okstate.edu. 
Participant Rights: 
Participation in this research is voluntary and there is no penalty for your refusal to participate. 
You are free to withdraw from the study at any time and revoke your consent to participate at any 
time without penalty. 
Signatures: 
I have read and fully understand the consent form. I sign it freely and voluntarily. A copy of this 
form has been given to me.  
         
Signature of Participant    Date 
I certify that I have personally explained this document before requesting that the participant sign 
it. 
         
Signature of Researcher    Date 
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